Cytospire Therapeutics Website
6 known investors
Cytospire Therapeutics develops multispecific antibodies and next-generation γδ T cell engagers designed to direct innate and adaptive immune effector cells as an alternative to CD3-based engagers. The company is building a portfolio of immune cell engagers aimed at cancer therapies.
Investors · 6
Frequently asked questions
- What does Cytospire Therapeutics Website do?
- Cytospire Therapeutics develops multispecific antibodies and next-generation γδ T cell engagers designed to direct innate and adaptive immune effector cells as an alternative to CD3-based engagers. The company is building a portfolio of immune cell engagers aimed at cancer therapies.
- Who are Cytospire Therapeutics Website's investors?
- Cytospire Therapeutics Website's investors include Criteria Bio Ventures, LifeArc Ventures, Medical Incubator Japan K.K., Modi Ventures, Pathway Bioventures, Sound Bioventures.